RetinaSense is an innovative precision retinal device, licensed from the University of Florida for sensing of active retinal tissue and is a breakthrough in enhancing outcomes for all vitreoretinal surgeries. Vitreoretinal surgery is an invasive microsurgical ocular procedure utilized to correct problems at or near the back of the eye. It is particularly useful for correcting retinal disorders, such as removal of various types of potentially vision-impairing or destructive epiretinal membranes (ERMs).

RetinaSense 2010 - an MDI Partners Company